MedTrace Logo

Interventions to Improve Bowel Cancer Screening Uptake in Ireland: a 2x2 Factorial Trial

NCT05609396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8734

Last updated 2022-11-14

No results posted yet for this study

Summary

High uptake is vital to population-based screening. BowelScreen (Irelands national organised population-based colorectal cancer screening programme) has not achieved recommended screening uptake targets. In Ireland sending the test kit in the screening invitation reminder may be an important strategy in targeting non-responders and would address a key difference between Ireland and other international screening programmes with higher uptake. In addition, few studies have focused on behavioural barriers to screening participation. Founded upon the MRC Guidelines for the Development of Complex Interventions, our systematic, theoretically-informed investigation of FIT screening participation has begun to identify behavioural antecedents to screening participation in Ireland. This study will implement a multilevel evidence-based, theoretically-informed intervention which includes the automatic inclusion of the test kit in the screening reminder, alone and in combination with an intervention to influence individuals' screening participation. This multilevel intervention will provide recommendations for the screening invitation delivery, potentially bringing the programme closer to recommended uptake targets (50%) and in the long-term influence reductions in bowel cancer incidence and mortality in Ireland.

Conditions

Interventions

BEHAVIORAL

Behaviorally enhanced reminder letter

Behavioral interventions to increase FIT-based colorectal cancer screening uptake

Sponsors & Collaborators

  • The National Screening Service

    collaborator UNKNOWN

  • Newcastle University

    collaborator OTHER

  • University College, London

    collaborator OTHER

  • University of Dublin, Trinity College

    collaborator OTHER

  • Dublin City University

    lead OTHER

Principal Investigators

  • Nicholas Clarke, PhD · DCU

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
60 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-03
Primary Completion
2022-10-24
Completion
2022-10-24

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05609396 on ClinicalTrials.gov